Yourgene Health plc YGEN “We are making excellent commercial progress”, claims newly appointed CEO Lyn Rees after revenues for the six months to the 30th September climbed by 45% and gross profit was up by 49%. The implementation of a further £1m annualised cost reduction program helped to bring the loss before tax down by 35%. Significant commercial progress was achieved during the half year, including the addition of new laboratories in Africa and Asia and the signing of a 3-year agreement with one of India’s leading diagnostics groups to offer mass-population non-invasive prenatal testing (“NIPT”) screening. Existing markets in India, the Middle East, Africa and South East Asia are being rapidly expanded.
ULS Technology plc ULS continued to increase its market share and grow revenue and profits during the half year to the 30th September, despite housing market transactions being lower year-on-year. ULS continued to out perform the market. Revenue inceased by 3%, underlying profit before tax by 6% and adjusted basic earnings per share by 7%. The interim dividend is increased by 4%.
Plastics Capital PLA reports continued strong organic revenue growth across the Group for the half year to the 30th September. Profit before tax and earnings per share both grew strongly by 75.4% and 67.9% respectively on revenue up by 11.4%. The company is now feeling the full effect of Sterling’s devaluation in 2016. Order books are healthy and good sales growth is expcted to continue for the foreseeable future.
Egdon Resources plc EGD reports a production update from the Ceres field which represents a material step up in both production and cash flow for Egdon. Gas sales net to Egdon for November are expected to be in excess of £235,000. Gas production from Ceres averaged 1.16 million cubic feet of gas per day (193 barrels of oil equivalent per day). following the installation of a new flow meter.